View Older Stories
-
Citi Upgrades BioAge Labs Inc (BIOA) to Buy
-
BioAge Labs (BIOA) files for 2.23M share offering by selling stockholders
-
BioAge Labs (BIOA) files $250M mixed shelf
-
BioAmber (BIOA) Reports Q2 Loss of $0.60
-
BioAge Labs (BIOA) expands drug discovery platform with samples from Norway's HUNT Biobank
-
Jefferies Reiterates Hold Rating on BioAge Labs Inc (BIOA)
-
BioAge Labs (BIOA) completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic
-
BioAge Labs (BIOA) recieves FDA orphan drug destination for exidavnemab
-
FINAL REMINDER BIOA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts BioAge Labs, Inc. Investors to Participate in the Class Action Lawsuit
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
-
FINAL BIOA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds BioAge Labs, Inc. Investors to Join the Class Action Lawsuit
-
BIOA DEADLINE TOMORROW: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities C
-
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
-
BIOA DEADLINE TOMORROW: BioAge Labs Investors are Notified to Contact BFA Law before Tomorrow's March 10 Class Action Deadline
-
BIOA FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Clas
-
BIOA LEGAL NOTICE: BioAge Labs Investors are Notified of Upcoming Class Action Deadline and are Urged to Contact BFA Law
-
BIOA DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - BIOA
-
BIOA DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - BIOA
-
BIOAGE LABS (BIOA) Investors have until March 10 before the Expiration of the Class Action Deadline and are Urged to Contact BFA Law
-
INVESTOR DEADLINE NEXT WEEK: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - BIOA
-
BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit - Hagens Berman
-
BIOA DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - BIOA
-
BIOA ALERT: BioAge Labs Investors are Alerted to Contact BFA Law before the Upcoming March 10 Class Action Deadline
-
BIOA IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class
-
BIOA STOCK NEWS: BioAge Labs Investors are Reminded to Contact BFA Law about the Pending Class Action before the March 10 Deadline
-
Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA
-
BIOA FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Act
-
BIOA DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action - BIOA
-
BIOA DEADLINE ALERT: BioAge Labs (BIOA) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 10th Deadline in Securities Class Action
-
BIOA CLASS ACTION: BFA Law Alerts BioAge Labs Investors to Contact the Firm Regarding the Ongoing Class Action and Upcoming Deadline
-
BIOA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action -
-
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
-
BIOA DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - BIOA
-
BIOA DEADLINE NOTICE: BFA Law Alerts BioAge Labs Investors that Lost Money to Contact the Firm by the March 10 Class Action Deadline
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
-
BIOA FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - BIOA
-
BIOA DEADLINE: BioAge Labs Investors are Alerted to Contact BFA Law before Imminent March 10 Class Action Deadline
-
BIOA FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
-
BIOA SECURITIES NOTICE: BioAge Investors that Suffered Losses are Alerted to Contact BFA Law before March 10 Deadline in Class Action
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
-
BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit - Hagens Berman
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
-
BIOA SECURITIES CLASS ACTION: BioAge Labs Investors that Suffered Losses are Reminded to Contact BFA Law before March 10 Legal Deadline
-
BIOA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
-
BIOA COURT NOTICE: BFA Law Reminds BioAge Labs Investors to Contact the Firm before March 10 Class Action Deadline
-
ROSEN, A TOP RANKED LAW FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA

